Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#191 / 200 Total
MLEC - Moolec Science SA - Stock Price Chart
TickerMLEC [NASD]
CompanyMoolec Science SA
CountryLuxembourg
IndustryBiotechnology
Market Cap54.46MEPS (ttm)-0.17
P/E-EPS this Y83.44%
Forward P/E-EPS next Y4.00%
PEG-EPS past 5Y-
P/S18.78EPS next 5Y-
P/B8.15EPS Q/Q39.10%
Dividend-Sales Q/Q-
Insider Own82.70%Inst Own0.04%
Insider Trans0.00%Inst Trans-39.74%
Short Float0.12%EarningsMar 13/b
Analyst Recom1.00Target Price6.00
Avg Volume1.40M52W Range1.15 - 4.40
Apr-22-24 08:01AM Why Is Moolec Science (MLEC) Stock Up 121% Today? (InvestorPlace) +76.43%
06:00AM Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins (ACCESSWIRE)
Mar-13-24 06:30AM Moolec Science Presents Second Quarter Fiscal Year 2024 Business Update (ACCESSWIRE)
Mar-06-24 08:00AM Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call (ACCESSWIRE)
Jan-11-24 09:35AM Down -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC) (Zacks) +26.50%
08:27AM Why Is Moolec Science (MLEC) Stock Up 40% Today? (InvestorPlace)
Dec-18-23 11:52AM MLEC Stock Earnings: Moolec Science Reported Results for Q1 2024 (InvestorPlace) +5.52%
Dec-14-23 06:00AM Moolec Science Presents First Quarter Fiscal Year 2024 Business Update (ACCESSWIRE)
Dec-07-23 08:00AM Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call (ACCESSWIRE)
Oct-20-23 05:00PM Moolec Science Presents Fourth Quarter FY 2023 Business Update (ACCESSWIRE)
MAIA - MAIA Biotechnology Inc - Stock Price Chart
TickerMAIA [AMEX]
CompanyMAIA Biotechnology Inc
CountryUSA
IndustryBiotechnology
Market Cap60.51MEPS (ttm)-1.45
P/E-EPS this Y-6.02%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-25.01%
P/S-EPS next 5Y-
P/B104.59EPS Q/Q2.67%
Dividend-Sales Q/Q-
Insider Own24.79%Inst Own3.85%
Insider Trans13.83%Inst Trans114.80%
Short Float5.07%EarningsNov 07/b
Analyst Recom1.00Target Price14.00
Avg Volume320.08K52W Range0.82 - 3.07
Apr-23-24 08:51AM MAIA Biotechnology Announces $1.00 Million Private Placement (Business Wire) +8.85%
Apr-05-24 08:01AM MAIA Biotechnology to Present at Two Investor Conferences in April 2024 (Business Wire) +6.82%
Mar-28-24 03:00PM MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero (Business Wire) -11.29%
Mar-26-24 03:00PM MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement (Business Wire)
08:01AM MAIA Biotechnology Announces $1.33 Million Private Placement (Business Wire)
Mar-22-24 03:00PM MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement (Business Wire) +8.76%
Mar-21-24 03:00PM MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board (Business Wire) +17.58%
Mar-16-24 01:49AM Director Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA) (GuruFocus.com)
Mar-07-24 09:45AM MAIA Biotechnology to Participate in the 36th Annual ROTH Conference (Business Wire)
Mar-06-24 11:04AM MAIA Biotechnology and Nationwide Childrens Hospital Announce Presentation of THIOs Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting (Business Wire)
ITRM - Iterum Therapeutics Plc - Stock Price Chart
TickerITRM [NASD]
CompanyIterum Therapeutics Plc
CountryIreland
IndustryBiotechnology
Market Cap27.44MEPS (ttm)-2.96
P/E-EPS this Y30.47%
Forward P/E-EPS next Y56.38%
PEG-EPS past 5Y19.62%
P/S-EPS next 5Y-
P/B-EPS Q/Q-126.55%
Dividend-Sales Q/Q-
Insider Own2.52%Inst Own6.94%
Insider Trans18.62%Inst Trans-12.14%
Short Float7.48%EarningsMar 28/b
Analyst Recom1.00Target Price6.50
Avg Volume615.39K52W Range0.62 - 2.50
Apr-02-24 10:22AM Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-29-24 12:09AM Q4 2023 Iterum Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 11:53AM ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
07:00AM Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-21-24 04:30PM Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 (GlobeNewswire)
Mar-15-24 08:00AM Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat (GlobeNewswire)
Mar-07-24 07:57AM Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up (Zacks)
Mar-06-24 08:00AM Iterum Therapeutics Provides Business Update (GlobeNewswire) +17.79%
Feb-01-24 03:03PM Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC (GuruFocus.com)
Jan-30-24 07:00AM Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections (PR Newswire) -11.73%
TFFP - Tff Pharmaceuticals Inc - Stock Price Chart
TickerTFFP [NASD]
CompanyTff Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap7.36MEPS (ttm)-12.68
P/E-EPS this Y54.77%
Forward P/E-EPS next Y4.66%
PEG-EPS past 5Y-13.86%
P/S-EPS next 5Y-
P/B0.72EPS Q/Q60.48%
Dividend-Sales Q/Q-
Insider Own1.74%Inst Own15.24%
Insider Trans0.00%Inst Trans11.67%
Short Float2.81%EarningsMar 28/a
Analyst Recom1.00Target Price24.50
Avg Volume31.85K52W Range2.51 - 21.25
Apr-15-24 07:00AM TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions (GlobeNewswire) -8.57%
Mar-28-24 10:54PM TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -8.35%
04:05PM TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-27-24 04:01PM TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs (GlobeNewswire)
Mar-25-24 09:01AM TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting (GlobeNewswire)
Mar-22-24 03:11PM TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -6.33%
Mar-20-24 12:00PM TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -10.37%
09:03AM TFF Pharmaceuticals Announces Update on Clinical Programs (GlobeNewswire)
Mar-14-24 04:47PM TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference March 17-19, 2024 (GlobeNewswire)
Jan-24-24 08:00AM TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference (GlobeNewswire) +10.88%
INTJ - Intelligent Group Ltd - Stock Price Chart
TickerINTJ [NASD]
CompanyIntelligent Group Ltd
CountryHong Kong
IndustryConsulting Services
Market Cap17.36MEPS (ttm)0.04
P/E33.08EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S6.62EPS next 5Y-
P/B7.83EPS Q/Q-48.09%
Dividend-Sales Q/Q56.98%
Insider Own68.61%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float1.05%Earnings-
Analyst Recom-Target Price-
Avg Volume668.77K52W Range1.32 - 7.87
Mar-19-24 08:47PM Intelligent Group Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq (GlobeNewswire)
SHIM - Shimmick Corp. - Stock Price Chart
TickerSHIM [NASD]
CompanyShimmick Corp.
CountryUSA
IndustryEngineering & Construction
Market Cap103.09MEPS (ttm)-
P/E-EPS this Y-143.75%
Forward P/E7.60EPS next Y352.38%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.44EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own92.25%Inst Own9.12%
Insider Trans0.00%Inst Trans-
Short Float2.59%EarningsMar 28/b
Analyst Recom1.00Target Price9.50
Avg Volume80.77K52W Range2.15 - 7.99
Mar-28-24 11:53AM SHIM Stock Earnings: Shimmick Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -15.29%
08:31AM Shimmick Corp (SHIM) Announces Fiscal Year 2023 Results with Mixed Performance (GuruFocus.com)
07:00AM Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2023 Results (GlobeNewswire)
Mar-26-24 04:55PM Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Dec-19-23 09:52PM SHIM Stock Earnings: Shimmick Reported Results for Q3 2023 (InvestorPlace)
05:58PM Shimmick Corp (SHIM) Reports Solid Earnings Amidst Strategic Shifts (GuruFocus.com)
04:05PM Shimmick Corp. Announces Third Quarter 2023 Results (GlobeNewswire)
Dec-15-23 08:00AM Shimmick Corporation Appoints Joe Del Guercio to Board of Directors (GlobeNewswire)
Dec-11-23 04:05PM Shimmick Corporation Announces Third Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Nov-13-23 08:26PM Shimmick Corporation Announces Pricing of Initial Public Offering (GlobeNewswire)
SAM - Boston Beer Co., Inc. - Stock Price Chart
TickerSAM [NYSE]
CompanyBoston Beer Co., Inc.
CountryUSA
IndustryBeverages - Brewers
Market Cap3.40BEPS (ttm)7.99
P/E35.46EPS this Y65.80%
Forward P/E22.70EPS next Y21.15%
PEG1.27EPS past 5Y-4.70%
P/S1.68EPS next 5Y27.89%
P/B3.24EPS Q/Q243.62%
Dividend-Sales Q/Q3.92%
Insider Own23.60%Inst Own62.32%
Insider Trans-0.02%Inst Trans-8.85%
Short Float2.96%EarningsApr 25/a
Analyst Recom3.29Target Price320.57
Avg Volume143.73K52W Range274.78 - 395.52
Apr-26-24 01:45PM Q1 2024 Boston Beer Company Inc Earnings Call (Thomson Reuters StreetEvents)
11:18AM UBS Raises Boston Beer's Price Target to $355 From $340, Maintains Neutral Rating (MT Newswires)
11:04AM Boston Beer (SAM) Stock Rallies on Q1 Earnings & Revenue Beat (Zacks)
10:31AM Dogfish Head Craft Brewery Unveils New Beer Packaging Artwork & Announces the Return of its Fan-Favorite 120 Minute IPA (GlobeNewswire)
09:28AM Analyst Report: The Boston Beer Company, Inc. (Morningstar Research)
09:03AM SAMUEL ADAMS TAPPED AS THE OFFICIAL BEER AND NON-ALCOHOLIC BEER OF THE PAN-MASS CHALLENGE (GlobeNewswire)
05:01AM Boston Beer Co Inc (SAM) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start with ... (GuruFocus.com)
Apr-25-24 06:15PM Boston Beer (SAM) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
05:35PM Boston Beer Co Inc (SAM) Surpasses Analyst Revenue Forecasts with Strong Q1 Performance (GuruFocus.com)
05:17PM Boston Beer: Q1 Earnings Snapshot (Associated Press Finance)
CGON - Cg Oncology Inc. - Stock Price Chart
TickerCGON [NASD, RUT]
CompanyCg Oncology Inc.
CountryUSA
IndustryBiotechnology
Market Cap2.73BEPS (ttm)-
P/E-EPS this Y76.25%
Forward P/E-EPS next Y-20.35%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own38.60%Inst Own3.87%
Insider Trans2.66%Inst Trans-
Short Float6.85%Earnings-
Analyst Recom1.40Target Price66.80
Avg Volume615.49K52W Range28.55 - 50.23
Apr-26-24 08:00AM CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024 (GlobeNewswire) +13.26%
Apr-24-24 10:00AM CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024 (GlobeNewswire)
Apr-11-24 10:02PM 20 Countries with the Most Domestically Listed Companies in the World (Insider Monkey)
Mar-28-24 08:00AM CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting (GlobeNewswire) +7.07%
Feb-27-24 08:00AM CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer (GlobeNewswire)
Jan-30-24 07:00AM CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares (Business Wire)
Jan-26-24 04:20PM In Bad News for IPO Market, BrightSpring Closes Below Offering Price (The Wall Street Journal) -5.76%
Jan-24-24 07:10PM CG Oncology Announces Pricing of Upsized Initial Public Offering (Business Wire)
LEXX - Lexaria Bioscience Corp - Stock Price Chart
TickerLEXX [NASD]
CompanyLexaria Bioscience Corp
CountryCanada
IndustryBiotechnology
Market Cap30.29MEPS (ttm)-1.13
P/E-EPS this Y47.03%
Forward P/E-EPS next Y7.48%
PEG-EPS past 5Y18.43%
P/S89.09EPS next 5Y-
P/B4.46EPS Q/Q79.57%
Dividend-Sales Q/Q42.89%
Insider Own8.67%Inst Own9.93%
Insider Trans0.00%Inst Trans9.21%
Short Float3.70%Earnings-
Analyst Recom1.00Target Price11.00
Avg Volume486.68K52W Range0.65 - 6.85
Apr-16-24 09:10AM Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study (ACCESSWIRE) +16.08%
Apr-09-24 09:52PM LEXX Stock Earnings: Lexaria Bioscience Beats EPS for Q2 2024 (InvestorPlace) -8.78%
Apr-02-24 09:00AM Lexaria Awarded New Patents (ACCESSWIRE)
Mar-21-24 09:20AM Lexaria to Present at The LD Micro Invitational XIV (Newsfile) -7.03%
Mar-14-24 09:20AM Lexaria Appoints Nelson Cabatuan as Chief Financial Officer (ACCESSWIRE) -12.50%
Mar-07-24 09:05AM Lexaria Awards Contract For Next GLP-1 Human Pilot Study (ACCESSWIRE) +11.61%
Mar-05-24 09:05AM Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1 (ACCESSWIRE) +12.67%
Mar-04-24 09:15AM 7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study (ACCESSWIRE)
Mar-01-24 08:20AM Lexaria Announces FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial (ACCESSWIRE) -15.36%
Feb-16-24 04:05PM Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (ACCESSWIRE) -9.32%
LFLY - Leafly Holdings Inc - Stock Price Chart
TickerLFLY [NASD]
CompanyLeafly Holdings Inc
CountryUSA
IndustryPharmaceutical Retailers
Market Cap4.69MEPS (ttm)-4.83
P/E-EPS this Y25.84%
Forward P/E-EPS next Y33.43%
PEG-EPS past 5Y-
P/S0.11EPS next 5Y-
P/B-EPS Q/Q93.51%
Dividend-Sales Q/Q-19.54%
Insider Own30.54%Inst Own9.60%
Insider Trans-0.16%Inst Trans-35.58%
Short Float4.00%EarningsMay 09/a
Analyst Recom2.33Target Price4.48
Avg Volume53.42K52W Range1.90 - 16.00
Apr-24-24 04:05PM Leafly to Announce First Quarter 2024 Financial Results on May 9, 2024 (Business Wire)
Apr-01-24 06:33PM Leafly Holdings, Inc. (NASDAQ:LFLY) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.46%
Mar-28-24 08:53PM LFLY Stock Earnings: Leafly Holdings Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:04PM Leafly Holdings, Inc. Announces Appointment of Two Cannabis Industry Veterans to Its Board (Business Wire)
04:02PM Leafly Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-05-24 05:15PM Leafly to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on March 28, 2024 (Business Wire) +7.40%
Dec-05-23 09:30AM Leafly 2023 Cannabis Strain of the Year is "Permanent Marker" (Business Wire) -6.28%
Nov-12-23 12:08PM Leafly Holdings, Inc. (NASDAQ:LFLY) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:02PM Leafly Holdings, Inc. Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-20-23 12:00PM Leafly Celebrates 3rd Annual International Budtenders Day (Business Wire)
1⋯10⋯151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.